All News #Library
Spectrum`s Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.
16 Jun 2023 //
FDA
Spectrum`s Biologic Rolvedon (Eflapegrastim) Receives Approval in the U.S.
09 Sep 2022 //
FDA
Spectrum Pharm’s Generic Bendamustine Hydrochloride Receives Approval In US
12 Dec 2017 //
FDA
Spectrum Pharm`s Evomela(Melphalan) approved in US as a chemotherapy drug
10 Mar 2016 //
FDA

Market Place
Sourcing Support